Last Updated: August 2, 2026

Epic Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for EPIC PHARMA

EPIC PHARMA has two hundred and one approved drugs.

There is one tentative approval on EPIC PHARMA drugs.

Summary for Epic Pharma

US Patents:	0
Tradenames:	169
Ingredients:	158
NDAs:	201

Drugs and US Patents for Epic Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Epic Pharma Llc	IVERMECTIN	ivermectin	TABLET;ORAL	218805-001	Sep 9, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Epic Pharma Llc	DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE	dorzolamide hydrochloride; timolol maleate	SOLUTION/DROPS;OPHTHALMIC	203058-001	Sep 22, 2014	AT1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Epic Pharma Llc	LEUCOVORIN CALCIUM	leucovorin calcium	TABLET;ORAL	074544-004	May 19, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Epic Pharma Llc	AZITHROMYCIN	azithromycin	FOR SUSPENSION;ORAL	207531-001	Apr 9, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Epic Pharma Llc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	203863-001	Mar 30, 2018	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Epic Pharma	BETAXOLOL HYDROCHLORIDE	betaxolol hydrochloride	TABLET;ORAL	075541-001	Oct 22, 1999	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Epic Pharma Llc	TRANDOLAPRIL	trandolapril	TABLET;ORAL	077256-003	Jun 12, 2007		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.